The cyclic peptide labaditin does not alter the outer membrane integrity of Salmonella enterica serovar Typhimurium

被引:0
作者
Simone C. Barbosa
Thatyane M. Nobre
Diogo Volpati
Eduardo M. Cilli
Daniel S. Correa
Osvaldo N. Oliveira
机构
[1] University of São Paulo,São Carlos Institute of Physics
[2] CP 369,Nanotechnology National Laboratory for Agriculture (LNNA)
[3] Sol Voltaics AB,undefined
[4] Universidade Estadual Paulista (UNESP),undefined
[5] Institute of Chemistry,undefined
[6] Embrapa Instrumentação,undefined
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Antimicrobial peptides are a promising class of new antibiotics with the ability to kill bacteria by disrupting their cell membrane, which is especially difficult for Gram-negative bacteria whose cell wall contains an outer layer of lipopolysaccharides (LPS). Here we show that the cyclic decapeptide Labaditin (Lo), with proven activity against the Gram-positive Staphylococcus aureus and Streptococcus mutans, is not able to kill the Gram-negative Salmonella enterica serovar Typhimurium (S.e.s. Typhimurium). We found that Lo induced significant changes in the surface pressure isotherms of Langmuir monolayers representing the Salmonella enterica serovar Typhimurium inner membrane (S.e.s. Typhimurium IM), and caused leakage in large unilamellar vesicles made with this IM lipid composition. On the basis of these results one should expect bactericidal activity against S.e.s. Typhimurium. However, Lo could not interact with a monolayer of LPS, causing no significant changes in either the surface pressure isotherms or in the polarization-modulated infrared reflection absorption spectra (PM-IRRAS). Therefore, the failure of Lo to kill S.e.s. Typhimurium is associated with the lack of interaction with LPS from the outer bacteria membrane. Our approach with distinct monolayer compositions and combined techniques to investigate molecular-level interactions is useful for drug design to fight antibiotic-resistant bacteria.
引用
收藏
相关论文
共 152 条
[1]  
Gal-Mor O(2014)Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ Frontiers in microbiology 5 391-843
[2]  
Boyle EC(2012)Host-pathogen interaction in invasive Salmonellosis PLoS pathogens 8 e1002933-522
[3]  
Grassl GA(1968)Lipids of Salmonella typhimurium and Escherichia coli: structure and metabolism J Bacteriol 95 833-816
[4]  
de Jong HK(2015)Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It ACS infectious diseases 1 512-854
[5]  
Parry CM(2009)Outer membrane permeability and antibiotic resistance Biochimica et biophysica acta 1794 808-21417
[6]  
van der Poll T(2012)Microbe-host interactions: structure and role of Gram-negative bacterial porins Curr Protein Pept Sci 13 843-1177
[7]  
Wiersinga WJ(2010)Directed epitope delivery across the Escherichia coli outer membrane through the porin OmpF Proceedings of the National Academy of Sciences of the United States of America 107 21412-12286
[8]  
Ames GF(2003)Mycobacterial porins–new channel proteins in unique outer membranes Molecular microbiology 49 1167-499
[9]  
Zgurskaya HI(2017)Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design Front Neurosci 11 73-344
[10]  
Lopez CA(2012)Antimicrobial Peptides for Therapeutic Applications: A Review Molecules 17 12276-257